Associate Director, Field Medical Operations and Capabilities- Interna…
Eli Lilly and CompanySalary not specified
- Full Time
- Senior (5 to 8 years)
Bristol-Myers Squibb
Associate Director, WW Medical Cardiovascular & Immunology, Portfolio Strategy & Business Development
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalIndustries
Requirements
Candidates should possess a Bachelor’s degree in a relevant scientific discipline, such as Biology, Pharmacology, or a related field, and have a minimum of 8 years of experience in medical affairs, portfolio strategy, or business development within the pharmaceutical industry. Strong analytical and strategic thinking skills are essential, along with demonstrated experience in conducting market research, competitive landscape analysis, and due diligence. Experience with cross-functional teams and stakeholder management is also required.
Responsibilities
The Associate Director will partner with the WW Medical Cardiovascular & Immunology Portfolio Strategy & Business Development Lead(s) to execute key deliverables around business development diligence and portfolio strategy refresh, including project management for aligning portfolio strategy initiatives with commercial and medical teams. They will also support leads with business development assessments and market research, engaging with internal stakeholders, and supporting the execution of the WW CV/IMM Medical planning on key early assets. Furthermore, the role involves supporting medical advisory boards and integrating the medical perspective into the commercialization and development process.
Skills
Market Research
Competitive Landscape Analysis
Due Diligence
Strategic Thinking
Project Management
Stakeholder Management
Cross-functional Teams
Medical Affairs
Portfolio Strategy
Business Development
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
Key Metrics
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees